Report Detail

Pharma & Healthcare Global Biologic Medical Product Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • RnM4474220
  • |
  • 28 July, 2022
  • |
  • Global
  • |
  • 124 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

The Biologic Medical Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Biologic Medical Product market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.

The Biologic Medical Product market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.

Tumor occupied for % of the Biologic Medical Product global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Biologic Medical Product include Roche, Amgen, AbbVie, Pfizer and Sanofi-Aventis, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Key Features of This Report:
This report provides in-depth analysis of the global Biologic Medical Product market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.

Main Biologic Medical Product companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This reports profiles key players in the global Biologic Medical Product market based on the following parameters – headquarters, products portfolio, Biologic Medical Product revenue, and gross margin, recent developments.

Evaluation and forecast the Biologic Medical Product market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Biologic Medical Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type (2017-2028; USD Million)
Monoclonal Antibodies
Colony-Stimulating Factor
Interferon
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others

Market segment by Application (2017-2028; USD Million)
Tumor
Diabetes
Cardiovascular
Hemophilia
Others

The key market players for global Biologic Medical Product market are listed below:
Roche
Amgen
AbbVie
Pfizer
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Ganlee
United Laboratories
Teva Pharmaceutical
MYLAN
Sun Pharma

Region Segment (2017-2028; USD Million)
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biologic Medical Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biologic Medical Product, with revenue, gross margin and global market share of Biologic Medical Product from 2019 to 2022.
Chapter 3, the Biologic Medical Product competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biologic Medical Product market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biologic Medical Product research findings and conclusion, appendix and data source


1 Market Overview

  • 1.1 Product Overview and Scope of Biologic Medical Product
  • 1.2 Classification of Biologic Medical Product by Type
    • 1.2.1 Overview: Global Biologic Medical Product Market Size by Type: 2017 Versus 2021 Versus 2028
    • 1.2.2 Global Biologic Medical Product Revenue Market Share by Type in 2021
    • 1.2.3 Monoclonal Antibodies
    • 1.2.4 Colony-Stimulating Factor
    • 1.2.5 Interferon
    • 1.2.6 Erythropoietin
    • 1.2.7 Insulin
    • 1.2.8 Vaccines
    • 1.2.9 Growth Hormones
    • 1.2.10 Others
  • 1.3 Global Biologic Medical Product Market by Application
    • 1.3.1 Overview: Global Biologic Medical Product Market Size by Application: 2017 Versus 2021 Versus 2028
    • 1.3.2 Tumor
    • 1.3.3 Diabetes
    • 1.3.4 Cardiovascular
    • 1.3.5 Hemophilia
    • 1.3.6 Others
  • 1.4 Global Biologic Medical Product Market Size & Forecast
  • 1.5 Global Biologic Medical Product Market Size and Forecast by Region
    • 1.5.1 Global Biologic Medical Product Market Size by Region: 2017 VS 2021 VS 2028
    • 1.5.2 Global Biologic Medical Product Market Size by Region, (2017-2022)
    • 1.5.3 North America Biologic Medical Product Market Size and Prospect (2017-2028)
    • 1.5.4 Europe Biologic Medical Product Market Size and Prospect (2017-2028)
    • 1.5.5 Asia-Pacific Biologic Medical Product Market Size and Prospect (2017-2028)
    • 1.5.6 South America Biologic Medical Product Market Size and Prospect (2017-2028)
    • 1.5.7 Middle East and Africa Biologic Medical Product Market Size and Prospect (2017-2028)
  • 1.6 Market Drivers, Restraints and Trends
    • 1.6.1 Biologic Medical Product Market Drivers
    • 1.6.2 Biologic Medical Product Market Restraints
    • 1.6.3 Biologic Medical Product Trends Analysis

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Biologic Medical Product Product and Solutions
    • 2.1.4 Roche Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Amgen
    • 2.2.1 Amgen Details
    • 2.2.2 Amgen Major Business
    • 2.2.3 Amgen Biologic Medical Product Product and Solutions
    • 2.2.4 Amgen Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.2.5 Amgen Recent Developments and Future Plans
  • 2.3 AbbVie
    • 2.3.1 AbbVie Details
    • 2.3.2 AbbVie Major Business
    • 2.3.3 AbbVie Biologic Medical Product Product and Solutions
    • 2.3.4 AbbVie Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.3.5 AbbVie Recent Developments and Future Plans
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Biologic Medical Product Product and Solutions
    • 2.4.4 Pfizer Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.4.5 Pfizer Recent Developments and Future Plans
  • 2.5 Sanofi-Aventis
    • 2.5.1 Sanofi-Aventis Details
    • 2.5.2 Sanofi-Aventis Major Business
    • 2.5.3 Sanofi-Aventis Biologic Medical Product Product and Solutions
    • 2.5.4 Sanofi-Aventis Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.5.5 Sanofi-Aventis Recent Developments and Future Plans
  • 2.6 Johnson & Johnson
    • 2.6.1 Johnson & Johnson Details
    • 2.6.2 Johnson & Johnson Major Business
    • 2.6.3 Johnson & Johnson Biologic Medical Product Product and Solutions
    • 2.6.4 Johnson & Johnson Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.6.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.7 Novo Nordisk
    • 2.7.1 Novo Nordisk Details
    • 2.7.2 Novo Nordisk Major Business
    • 2.7.3 Novo Nordisk Biologic Medical Product Product and Solutions
    • 2.7.4 Novo Nordisk Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.7.5 Novo Nordisk Recent Developments and Future Plans
  • 2.8 Eli Lilly
    • 2.8.1 Eli Lilly Details
    • 2.8.2 Eli Lilly Major Business
    • 2.8.3 Eli Lilly Biologic Medical Product Product and Solutions
    • 2.8.4 Eli Lilly Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.8.5 Eli Lilly Recent Developments and Future Plans
  • 2.9 Novartis
    • 2.9.1 Novartis Details
    • 2.9.2 Novartis Major Business
    • 2.9.3 Novartis Biologic Medical Product Product and Solutions
    • 2.9.4 Novartis Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.9.5 Novartis Recent Developments and Future Plans
  • 2.10 Merck
    • 2.10.1 Merck Details
    • 2.10.2 Merck Major Business
    • 2.10.3 Merck Biologic Medical Product Product and Solutions
    • 2.10.4 Merck Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.10.5 Merck Recent Developments and Future Plans
  • 2.11 Sun
    • 2.11.1 Sun Details
    • 2.11.2 Sun Major Business
    • 2.11.3 Sun Biologic Medical Product Product and Solutions
    • 2.11.4 Sun Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.11.5 Sun Recent Developments and Future Plans
  • 2.12 3sbio
    • 2.12.1 3sbio Details
    • 2.12.2 3sbio Major Business
    • 2.12.3 3sbio Biologic Medical Product Product and Solutions
    • 2.12.4 3sbio Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.12.5 3sbio Recent Developments and Future Plans
  • 2.13 Changchun High Tech
    • 2.13.1 Changchun High Tech Details
    • 2.13.2 Changchun High Tech Major Business
    • 2.13.3 Changchun High Tech Biologic Medical Product Product and Solutions
    • 2.13.4 Changchun High Tech Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.13.5 Changchun High Tech Recent Developments and Future Plans
  • 2.14 CP Guojian
    • 2.14.1 CP Guojian Details
    • 2.14.2 CP Guojian Major Business
    • 2.14.3 CP Guojian Biologic Medical Product Product and Solutions
    • 2.14.4 CP Guojian Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.14.5 CP Guojian Recent Developments and Future Plans
  • 2.15 Biotech
    • 2.15.1 Biotech Details
    • 2.15.2 Biotech Major Business
    • 2.15.3 Biotech Biologic Medical Product Product and Solutions
    • 2.15.4 Biotech Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.15.5 Biotech Recent Developments and Future Plans
  • 2.16 Gelgen
    • 2.16.1 Gelgen Details
    • 2.16.2 Gelgen Major Business
    • 2.16.3 Gelgen Biologic Medical Product Product and Solutions
    • 2.16.4 Gelgen Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.16.5 Gelgen Recent Developments and Future Plans
  • 2.17 Innovent
    • 2.17.1 Innovent Details
    • 2.17.2 Innovent Major Business
    • 2.17.3 Innovent Biologic Medical Product Product and Solutions
    • 2.17.4 Innovent Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.17.5 Innovent Recent Developments and Future Plans
  • 2.18 Ganlee
    • 2.18.1 Ganlee Details
    • 2.18.2 Ganlee Major Business
    • 2.18.3 Ganlee Biologic Medical Product Product and Solutions
    • 2.18.4 Ganlee Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.18.5 Ganlee Recent Developments and Future Plans
  • 2.19 United Laboratories
    • 2.19.1 United Laboratories Details
    • 2.19.2 United Laboratories Major Business
    • 2.19.3 United Laboratories Biologic Medical Product Product and Solutions
    • 2.19.4 United Laboratories Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.19.5 United Laboratories Recent Developments and Future Plans
  • 2.20 Teva Pharmaceutical
    • 2.20.1 Teva Pharmaceutical Details
    • 2.20.2 Teva Pharmaceutical Major Business
    • 2.20.3 Teva Pharmaceutical Biologic Medical Product Product and Solutions
    • 2.20.4 Teva Pharmaceutical Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.20.5 Teva Pharmaceutical Recent Developments and Future Plans
  • 2.21 MYLAN
    • 2.21.1 MYLAN Details
    • 2.21.2 MYLAN Major Business
    • 2.21.3 MYLAN Biologic Medical Product Product and Solutions
    • 2.21.4 MYLAN Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.21.5 MYLAN Recent Developments and Future Plans
  • 2.22 Sun Pharma
    • 2.22.1 Sun Pharma Details
    • 2.22.2 Sun Pharma Major Business
    • 2.22.3 Sun Pharma Biologic Medical Product Product and Solutions
    • 2.22.4 Sun Pharma Biologic Medical Product Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    • 2.22.5 Sun Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biologic Medical Product Revenue and Share by Players (2019, 2020, 2021, and 2022)
  • 3.2 Market Concentration Rate
    • 3.2.1 Top 3 Biologic Medical Product Players Market Share in 2021
    • 3.2.2 Top 10 Biologic Medical Product Players Market Share in 2021
    • 3.2.3 Market Competition Trend
  • 3.3 Biologic Medical Product Players Head Office, Products and Services Provided
  • 3.4 Biologic Medical Product Mergers & Acquisitions
  • 3.5 Biologic Medical Product New Entrants and Expansion Plans

4 Market Size Segment by Type

  • 4.1 Global Biologic Medical Product Revenue and Market Share by Type (2017-2022)
  • 4.2 Global Biologic Medical Product Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

  • 5.1 Global Biologic Medical Product Revenue Market Share by Application (2017-2022)
  • 5.2 Global Biologic Medical Product Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

  • 6.1 North America Biologic Medical Product Revenue by Type (2017-2028)
  • 6.2 North America Biologic Medical Product Revenue by Application (2017-2028)
  • 6.3 North America Biologic Medical Product Market Size by Country
    • 6.3.1 North America Biologic Medical Product Revenue by Country (2017-2028)
    • 6.3.2 United States Biologic Medical Product Market Size and Forecast (2017-2028)
    • 6.3.3 Canada Biologic Medical Product Market Size and Forecast (2017-2028)
    • 6.3.4 Mexico Biologic Medical Product Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

  • 7.1 Europe Biologic Medical Product Revenue by Type (2017-2028)
  • 7.2 Europe Biologic Medical Product Revenue by Application (2017-2028)
  • 7.3 Europe Biologic Medical Product Market Size by Country
    • 7.3.1 Europe Biologic Medical Product Revenue by Country (2017-2028)
    • 7.3.2 Germany Biologic Medical Product Market Size and Forecast (2017-2028)
    • 7.3.3 France Biologic Medical Product Market Size and Forecast (2017-2028)
    • 7.3.4 United Kingdom Biologic Medical Product Market Size and Forecast (2017-2028)
    • 7.3.5 Russia Biologic Medical Product Market Size and Forecast (2017-2028)
    • 7.3.6 Italy Biologic Medical Product Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

  • 8.1 Asia-Pacific Biologic Medical Product Revenue by Type (2017-2028)
  • 8.2 Asia-Pacific Biologic Medical Product Revenue by Application (2017-2028)
  • 8.3 Asia-Pacific Biologic Medical Product Market Size by Region
    • 8.3.1 Asia-Pacific Biologic Medical Product Revenue by Region (2017-2028)
    • 8.3.2 China Biologic Medical Product Market Size and Forecast (2017-2028)
    • 8.3.3 Japan Biologic Medical Product Market Size and Forecast (2017-2028)
    • 8.3.4 South Korea Biologic Medical Product Market Size and Forecast (2017-2028)
    • 8.3.5 India Biologic Medical Product Market Size and Forecast (2017-2028)
    • 8.3.6 Southeast Asia Biologic Medical Product Market Size and Forecast (2017-2028)
    • 8.3.7 Australia Biologic Medical Product Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

  • 9.1 South America Biologic Medical Product Revenue by Type (2017-2028)
  • 9.2 South America Biologic Medical Product Revenue by Application (2017-2028)
  • 9.3 South America Biologic Medical Product Market Size by Country
    • 9.3.1 South America Biologic Medical Product Revenue by Country (2017-2028)
    • 9.3.2 Brazil Biologic Medical Product Market Size and Forecast (2017-2028)
    • 9.3.3 Argentina Biologic Medical Product Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

  • 10.1 Middle East & Africa Biologic Medical Product Revenue by Type (2017-2028)
  • 10.2 Middle East & Africa Biologic Medical Product Revenue by Application (2017-2028)
  • 10.3 Middle East & Africa Biologic Medical Product Market Size by Country
    • 10.3.1 Middle East & Africa Biologic Medical Product Revenue by Country (2017-2028)
    • 10.3.2 Turkey Biologic Medical Product Market Size and Forecast (2017-2028)
    • 10.3.3 Saudi Arabia Biologic Medical Product Market Size and Forecast (2017-2028)
    • 10.3.4 UAE Biologic Medical Product Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

    12 Appendix

    • 12.1 Methodology
    • 12.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biologic Medical Product. Industry analysis & Market Report on Biologic Medical Product is a syndicated market report, published as Global Biologic Medical Product Market 2022 by Company, Regions, Type and Application, Forecast to 2028. It is complete Research Study and Industry Analysis of Biologic Medical Product market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $6,960.00
    2,881.44
    5,762.88
    3,406.92
    6,813.84
    469,869.60
    939,739.20
    276,555.60
    553,111.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report